SG10201804505VA - Near-infrared fluorescent contrast bioimaging agents and methods of use thereof - Google Patents

Near-infrared fluorescent contrast bioimaging agents and methods of use thereof

Info

Publication number
SG10201804505VA
SG10201804505VA SG10201804505VA SG10201804505VA SG10201804505VA SG 10201804505V A SG10201804505V A SG 10201804505VA SG 10201804505V A SG10201804505V A SG 10201804505VA SG 10201804505V A SG10201804505V A SG 10201804505VA SG 10201804505V A SG10201804505V A SG 10201804505VA
Authority
SG
Singapore
Prior art keywords
methods
infrared fluorescent
fluorescent contrast
bioimaging
agents
Prior art date
Application number
SG10201804505VA
Inventor
John V Frangioni
Hak Soo Choi
Maged M Henary
Original Assignee
Beth Israel Deaconess Medical Ct Inc
Univ Georgia State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beth Israel Deaconess Medical Ct Inc, Univ Georgia State Res Found filed Critical Beth Israel Deaconess Medical Ct Inc
Publication of SG10201804505VA publication Critical patent/SG10201804505VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0028—Oxazine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/003—Thiazine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B17/00—Azine dyes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B19/00—Oxazine dyes
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/0008—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain
    • C09B23/0016—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain the substituent being a halogen atom
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/0008—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain
    • C09B23/0025—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain the substituent being bound through an oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/0008—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain
    • C09B23/0033—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain the substituent being bound through a sulfur atom
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/0008—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain
    • C09B23/0041—Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain the substituent being bound through a nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/0066—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid)
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • C09B23/04—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups one >CH- group, e.g. cyanines, isocyanines, pseudocyanines
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • C09B23/08—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines
    • C09B23/083—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines five >CH- groups
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • C09B23/08—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines
    • C09B23/086—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines more than five >CH- groups
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B57/00—Other synthetic dyes of known constitution
    • C09B57/10—Metal complexes of organic compounds not being dyes in uncomplexed form
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B69/00—Dyes not provided for by a single group of this subclass
    • C09B69/008—Dyes containing a substituent, which contains a silicium atom
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/4833—Physical analysis of biological material of solid biological material, e.g. tissue samples, cell cultures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Oncology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • User Interface Of Digital Computer (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

NEAR-INFRARED FLUORESCENT CONTRAST BIOIMAGING AGENTS AND METHODS OF USE THEREOF ηe instant inv 臼1tion provides near­ methods of using th 缸n . N o Fig. for publication -223-
SG10201804505VA 2013-10-31 2014-10-30 Near-infrared fluorescent contrast bioimaging agents and methods of use thereof SG10201804505VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361898424P 2013-10-31 2013-10-31
US201461929916P 2014-01-21 2014-01-21

Publications (1)

Publication Number Publication Date
SG10201804505VA true SG10201804505VA (en) 2018-07-30

Family

ID=53005106

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201603403WA SG11201603403WA (en) 2013-10-31 2014-10-30 Near-infrared fluorescent contrast bioimaging agents and methods of use thereof
SG10201804505VA SG10201804505VA (en) 2013-10-31 2014-10-30 Near-infrared fluorescent contrast bioimaging agents and methods of use thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201603403WA SG11201603403WA (en) 2013-10-31 2014-10-30 Near-infrared fluorescent contrast bioimaging agents and methods of use thereof

Country Status (8)

Country Link
US (2) US11077210B2 (en)
EP (2) EP4147724A1 (en)
JP (5) JP7023604B2 (en)
AU (3) AU2014342254B2 (en)
CA (2) CA3227320A1 (en)
ES (1) ES2929194T3 (en)
SG (2) SG11201603403WA (en)
WO (1) WO2015066290A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201516987D0 (en) 2015-09-25 2015-11-11 Illumina Cambridge Ltd Polymethine compounds and their use as fluorescent labels
JP6752582B2 (en) * 2016-02-08 2020-09-09 キヤノン株式会社 Contrast agent for photoacoustic imaging
JP6776672B2 (en) * 2016-07-08 2020-10-28 住友電気工業株式会社 Quality evaluation method and quality evaluation equipment
KR101804063B1 (en) 2016-08-03 2017-12-01 전남대학교산학협력단 Tumor targeting near-infrared fluorophore
KR101774345B1 (en) * 2016-08-29 2017-09-04 전남대학교산학협력단 Calcification targeting near-infrared fluorophore
US20230192675A1 (en) * 2017-04-03 2023-06-22 Ellen M. Sletten Near and shortwave infrared polymethine dyes
GB2567124A (en) * 2017-05-08 2019-04-10 Vysoka Akola Chemicko Tech V Praze Imaging agents and methods
US11292778B2 (en) 2017-06-05 2022-04-05 The Regents Of The University Of California Heterocyclyl polymethine IR chromophores
WO2019126565A1 (en) * 2017-12-20 2019-06-27 The Regents Of The University Of Colorado, A Body Corporate Lipid derivatives for in vitro or in vivo delivery
WO2019136590A1 (en) * 2018-01-09 2019-07-18 深圳大学 Pentamethine cyanine dye and preparation method therefor
WO2020159448A1 (en) * 2019-02-01 2020-08-06 Nanyang Technological University Molecular renal probes for detecting acute kidney injury
KR102027311B1 (en) 2019-03-27 2019-10-02 주식회사 티젤바이오 Method of preparing nanoplateform-based diagnostic agent for selectively staining of inflammatory abnormal tissue or tumor tissue
NL2022828B1 (en) * 2019-03-28 2020-10-06 Hq Medical Netherlands B V Targeting compounds for cancers selected from pancreas, pharynx and larynx, lung, breast, and intestines
KR102318505B1 (en) * 2019-04-26 2021-10-27 서울대학교산학협력단 Bone-specific complex comprising osteogenic recombinant protein and bone targeting agent
KR102034113B1 (en) * 2019-06-13 2019-10-18 나우비젼 주식회사 Renal clearable tumor-specific fluorophores and their imaging methods
BR112022014580A2 (en) * 2020-01-24 2022-09-27 Univ Oregon Health & Science OXAZINE-BASED FLUOROPHORE COMPOUNDS FOR NERVO-SPECIFIC IMAGING
NL2027653B1 (en) 2021-02-25 2022-09-20 Coretag Holding A G Targeting system with improved uptake
WO2022196694A1 (en) * 2021-03-15 2022-09-22 国立研究開発法人理化学研究所 Compound, production method therefor, complex, and short wavelength infrared fluorescent agent
WO2023287686A1 (en) * 2021-07-12 2023-01-19 The University Of North Carolina At Chapel Hill Labeled compounds and calcium sensing receptor ligands for imaging and uses thereof
CN114014843B (en) * 2021-11-17 2022-09-20 北京大学第一医院 PSMA targeted nuclide/fluorescent bimodal ligand, molecular probe and application
WO2023114248A1 (en) * 2021-12-16 2023-06-22 Curadel Surgical Innovations, Inc. Near-infrared fluorescent contrast bioimaging agents for imaging of sentinel lymph nodes
WO2023154762A1 (en) * 2022-02-08 2023-08-17 The General Hospital Corporation Squaraine fluorophores
CN114957082B (en) * 2022-06-22 2024-03-26 苏州优逸兰迪生物科技有限公司 Lysosome targeting fluorescent probe and preparation method and application thereof
KR20240014334A (en) * 2022-07-25 2024-02-01 한국생명공학연구원 Fluorescent Probe Compound and Composite Comprising the Same
WO2024044536A2 (en) * 2022-08-20 2024-02-29 The Board Of Trustees Of The University Of Illinois Tumor-seeking glucose-dendrons for the delivery of chemotherapeutics and imaging agent to cancer cells
WO2024044539A2 (en) * 2022-08-21 2024-02-29 The Board Of Trustees Of The University Of Illinois Nir-light activatable nanogel delivery system
EP4360659A1 (en) * 2022-10-26 2024-05-01 Cyanagen S.r.l. Fluorescent water-soluble polycationic chitosan polymers as markers for biological 3d imaging
CN117186151B (en) * 2023-08-23 2024-05-17 中山大学 Near-infrared zwitterionic cyanine dye and preparation method and application thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0613238B2 (en) * 1982-11-08 1994-02-23 株式会社リコー Optical information recording medium
JPH05150395A (en) * 1991-11-28 1993-06-18 Canon Inc Dry type silver salt photosensitive body and method for forming image by using same
DE4445065A1 (en) 1994-12-07 1996-06-13 Diagnostikforschung Inst Methods for in-vivo diagnostics using NIR radiation
JP2000095758A (en) 1998-09-18 2000-04-04 Schering Ag Near-infrared, fluorescent contrast medium, and its production
US20030026762A1 (en) 1999-05-05 2003-02-06 Malmros Mark K. Bio-spectral imaging system and methods for diagnosing cell disease state
US7527787B2 (en) * 2005-10-19 2009-05-05 Ibc Pharmaceuticals, Inc. Multivalent immunoglobulin-based bioactive assemblies
US6440389B1 (en) * 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
JP4156784B2 (en) * 2000-07-25 2008-09-24 富士フイルム株式会社 Negative-type image recording material and image forming method
US7101999B2 (en) * 2000-09-06 2006-09-05 Evotec Ag Oxazine derivatives
WO2002038190A2 (en) 2000-10-27 2002-05-16 Beth Israel Deaconess Medical Center Non-isotopic detection of osteoblastic activity in vivo using modified bisphosphonates
US6730461B2 (en) * 2001-10-26 2004-05-04 Eastman Kodak Company Thermally developable imaging materials with reduced mottle providing improved image uniformity
JP2004121292A (en) * 2002-09-30 2004-04-22 Hayashibara Biochem Lab Inc Receptor potential inducer
US7682603B2 (en) * 2003-07-25 2010-03-23 The Trustees Of The University Of Pennsylvania Polymersomes incorporating highly emissive probes
AU2003272531A1 (en) 2003-09-15 2005-04-27 Beth Israel Deaconess Medical Center Medical imaging systems
GB0322756D0 (en) 2003-09-29 2003-10-29 Univ Aberdeen Methods of chemical synthesis
US20080308744A1 (en) 2003-11-18 2008-12-18 Beth Israel Deaconess Medical Center Serum Albumin Conjugated to Fluorescent Substances for Imaging
EP1624071B1 (en) 2004-08-06 2008-10-22 Fuji Electric Holdings Co., Ltd. Method of detecting viable cells
FR2889700B1 (en) 2005-08-11 2012-11-23 Synthinnove Lab MARKERS, METHOD FOR PRODUCING THE SAME, AND APPLICATIONS THEREOF
JP5416970B2 (en) 2005-09-02 2014-02-12 ビセン メディカル， インコーポレイテッド Nicotinic acid and picolinic acid-derived near-infrared fluorophores
CA2655257A1 (en) * 2006-06-12 2008-12-04 Bipar Sciences, Inc. Method of treating diseases with parp inhibitors
CL2007003044A1 (en) * 2006-10-24 2008-07-04 Wyeth Corp COMPOUNDS DERIVED FROM BENZOXAZINA; PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS THEM; AND USE FOR THE TREATMENT OF A PSYCHOTIC, BIPOLAR, DEPRESSIVE AND ABUSE DISORDER OR DEPENDENCE OF SUBSTANCES BETWEEN OTHERS.
WO2009061473A2 (en) 2007-11-07 2009-05-14 Mallinckrodt Inc. Photonic shell-core cross linked and functionalized nanostructures for biological applications
JP5150395B2 (en) 2008-07-22 2013-02-20 株式会社東芝 Cushioning material and packing box
EP2428230A1 (en) 2008-12-25 2012-03-14 Canon Kabushiki Kaisha Probe for auditory hair cells.
ES2684697T3 (en) * 2009-02-06 2018-10-04 Beth Israel Deaconess Medical Center, Inc. Agents for obtaining balanced load images
ES2782334T3 (en) 2009-02-25 2020-09-14 Basf Se Composition of hair dye
AU2010236189B2 (en) 2009-04-17 2015-01-29 Li-Cor, Inc. Fluorescent imaging with substituted cyanine dyes
ES2670818T3 (en) 2010-04-01 2018-06-01 D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. Staining composition for use in an eye surgery method
GB201019118D0 (en) 2010-11-11 2010-12-29 King S College Conjugates and their uses in molecular imaging
US11572475B2 (en) * 2011-07-18 2023-02-07 Georgia State University Research Foundation, Inc. Carbocyanines for G-quadruplex DNA stabilization and telomerase inhibition
US20130030282A1 (en) * 2011-07-18 2013-01-31 Bar Ilan University Synthesis and characterization of near ir fluorescent magnetic and non-magnetic albumin nanoparticles for biomedical applications
US9138492B2 (en) 2012-02-23 2015-09-22 Canon Kabushiki Kaisha Particle containing hydrophobic dye having cyanine structure, and contrast agent containing the particle
CN102722276B (en) 2012-03-27 2015-11-25 北京京东方光电科技有限公司 Touch sensor and preparation method thereof and touch screen LCD

Also Published As

Publication number Publication date
JP2020138974A (en) 2020-09-03
EP3062825A4 (en) 2018-03-14
AU2020204233A1 (en) 2020-07-16
US11077210B2 (en) 2021-08-03
WO2015066290A1 (en) 2015-05-07
US20160263249A1 (en) 2016-09-15
EP3062825A1 (en) 2016-09-07
AU2014342254A1 (en) 2016-06-09
AU2014342254B2 (en) 2020-03-26
CA3227320A1 (en) 2015-05-07
JP2019077716A (en) 2019-05-23
CA2929116A1 (en) 2015-05-07
AU2020204233B2 (en) 2022-07-21
JP2022078023A (en) 2022-05-24
US20220387631A1 (en) 2022-12-08
CA2929116C (en) 2024-02-27
AU2022256125A1 (en) 2022-11-24
EP4147724A1 (en) 2023-03-15
ES2929194T3 (en) 2022-11-25
SG11201603403WA (en) 2016-05-30
JP2023111939A (en) 2023-08-10
JP7023604B2 (en) 2022-02-22
JP2017503004A (en) 2017-01-26
EP3062825B1 (en) 2022-08-24

Similar Documents

Publication Publication Date Title
SG10201804505VA (en) Near-infrared fluorescent contrast bioimaging agents and methods of use thereof
MY191169A (en) Anti-fcrh5 antibodies
PH12020550781A1 (en) Anti-jagged1 antibodies and methods of use
PH12017500877A1 (en) ANTI-CD79b ANTIBODIES AND METHODS OF USE
PH12015501954A1 (en) Anti-b7-h4 antibodies and immunoconjugates
PH12016501143A1 (en) Anti-cd33 antibodies and immunoconjugates
MY193661A (en) Anti-tim3 antibodies and methods of use
MX2020008436A (en) ANTI-alpha-SYNUCLEIN ANTIBODIES AND METHODS OF USE.
PH12016501894B1 (en) Anti-ox40 antibodies and methods of use
MX2015012326A (en) Anti-crth2 antibodies and their use.
MX2020010141A (en) Anti-complement factor c1q antibodies and uses thereof.
PH12014502132A1 (en) Anti-lgr5 antibodies and immunoconjugates
MX342240B (en) Anti-fgfr4 antibodies and methods of use.
PH12014502601A1 (en) ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE
MX2014004022A (en) ANTI-HtrA1 ANTIBODIES AND METHODS OF USE.
MX2013015311A (en) Pcsk9-binding polypeptides and methods of use.
MX2013007168A (en) Anti-pcsk9 antibodies and methods of use.
PH12014501605A1 (en) Anti-lrp5 antibodies and methods of use
MX2014002053A (en) Anti-mcsp antibodies.
MX354303B (en) Anti-biotin antibodies and methods of use.
MX2016004853A (en) ANTI-Ly6E ANTIBODIES AND METHODS OF USE.
MX336323B (en) Anti-polyubiquitin antibodies and methods of use.
MX357675B (en) Anti-jagged anitbodies and methods of use.
MX2014014381A (en) Anti-theophylline antibodies and methods of use.
MX2016004573A (en) Nsp4 inhibitors and methods of use.